Cancer News and Research

Latest Cancer News and Research

IDM Pharma receives not approvable letter for Mifamurtide for treatment of osteosarcoma

IDM Pharma, Inc. ( NASDAQ:IDMI ) announced today that it received a not approvable letter from the U.S. Food and Drug Administration (FDA) after completing the review of the new drug application (NDA) for the investigational drug mifamurtide (L-MTP-PE), formerly known as Junovan, for the treatment of non-metastatic osteosarcoma, a rare and often fatal bone tumor that typically affects children and young adults.

28 Aug 2007

New understanding of factor YY1 in gene expression

The Conaway Lab - led by Joan Conaway, Ph.D., and Ron Conaway, Ph.D., Investigators - has published findings that shed light on the role of the much-studied transcription factor YY1 in gene expression.

28 Aug 2007

Breast epithelial cells serve as a barrier against cancer

Sheets of highly organized epithelial cells line all the cavities and free surfaces of the body, forming barriers that control the movement of liquids and cells in the body organs.

28 Aug 2007

Womens' head and neck cancer risk up 75 percent when they smoke

According to the National Cancer Institute (NCI), a new study suggests that smoking can increase a person's risk of developing head and neck cancer.

28 Aug 2007

Oral sex the culprit in rising numbers of throat cancers

According to the latest figures on head and neck cancer, even though the rates for such cancers have dropped in recent years, throat cancer rates in the United States have not dropped.

28 Aug 2007

Moderate drinkers less likely to get kidney cancer

The researchers at the Karolinska Institute in Stockholm suggest that people who drink 22 ounces of alcohol a week are 40 percent less likely to develop kidney cancer.

28 Aug 2007

Cancer Research Technology begins critical role in new Australian cancer research venture

Cancer Research Technology Ltd (CRT) today announces the start of its key role within an ambitious new Australia-based collaboration, Cancer Therapeutics CRC Pty Ltd (CTx), which commenced operations today.

28 Aug 2007

Scientists reveal the actions of a key player in colorectal cancer

Colorectal cancer is one of the most prevalent cancers in the Western world. The tumor starts off as a polyp but then turns into an invasive and violent cancer, which often spreads to the liver.

28 Aug 2007

Novel approach used to uncover genetic components of aging

People who live to 100 or more are known to have just as many - and sometimes even more - harmful gene variants compared with younger people.

26 Aug 2007

Smoking turns on genes

Smoking tobacco is no longer considered sexy, but it may prove a permanent turn on for some genes.

26 Aug 2007

Avastin approved in Europe for advanced lung cancer

Avastin (bevacizumab), Roche's innovative anti-cancer drug, was approved today in Europe for the first-line treatment of patients with advanced non-small cell lung cancer (NSCLC), in combination with platinum-based chemotherapy.

26 Aug 2007

Oglufanide disodium in new hepatitis C trial

Physicians at Southern Health have started a phase IIa clinical trial designed to test the efficacy of a new strategy for defeating hepatitis C viral infection, one of the toughest infectious diseases in the modern world.

26 Aug 2007

Bacterial toxins and perforins have a common ancestor

Human immune proteins crucial for fighting cancer, viruses and bacterial infections belong to an ancient and lethal toxin family previously only found in bacteria, Australian researchers have found.

24 Aug 2007

Non-stick cookware linked to lower birth weight

Babies exposed to chemicals used in non-stick cookware and other consumer products while in their mother's womb were born at a significantly lower body weight, according a new study published in Environmental Health Perspectives , a publication of the National Institute for Environmental Health Sciences.

24 Aug 2007

Blocking angiogenesis signaling from inside cell may lead to serious health problems

Angiogenesis inhibitors that block a tumor's development of an independent blood supply have been touted as effective cancer fighters that result in fewer side effects than traditional chemotherapy.

24 Aug 2007

Night shift work and cancer - no link found

Working the night shift doesn't appear to increase the risk of developing cancer, suggest the findings of a new study of Swedish workers.

24 Aug 2007

Networking in living cells may hold key to fighting diseases

Scientists in Manchester are working to change the social habits of living cells an innovation that could bring about cleaner and greener fuel and help fight diseases such as cancer and diabetes.

From The University of Manchester 24 Aug 2007

Nanoparticle drug delivery system for brain tumor therapy shows promise

A nanoparticle drug delivery system designed for brain tumor therapy has shown promising tumor cell selectivity in a novel cell culture model devised by University of Nottingham scientists.

24 Aug 2007

Potential new leukemia drug

In a new study, Danilo Perrotti and colleagues from Ohio State University, Columbus, show that treatment with a drug known as FTY720 prevents disease in a mouse model of many leukemias caused by the cancer protein BCR-ABL (nearly all cases of blast crisis chronic myeloid leukemia [CML-BC] and some cases of acute lymphocytic leukemia [ALL]).

24 Aug 2007

Nuclear nanocapsules to target tiny tumors

Rice University chemists have found a way to package some of nature's most powerful radioactive particles inside DNA-sized tubes of pure carbon -- a method they hope to use to target tiny tumors and even lone leukemia cells.

24 Aug 2007